Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 9
- Markets & Stocks
Synbiotic Acquires Greensby, Stenocare Offloads Cultivation Operations, & Hellenic Faces Second Liquidation Petition
Hellenic Dynamics Hellenic Dynamics is facing down its second petition for compulsory liquidation this year as it continues to endure funding delays.
- Markets & Stocks
Celadon Hit by Cash Crunch Amid Funding Delays, Danish Companies Spike on Medical Cannabis Expansion, & Tilray Launches German Grown Products
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] UK-based medical cannabis producer Celadon Pharmaceuticals has seen its stock tank by 40% this week as its funding crisis hits a critical juncture.
- Markets & Stocks
Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding
Cantourage Group [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Cantourage has continued its run of positive financial results, reporting record profits for the third quarter and nearly doubling revenues year-on-year.
- Companies
Billions Wiped of US Cannabis Companies’ Market Value Amid Mixed Financial Performance in Q3
US cannabis companies have endured a significant selloff in the days following the results of the election, seeing $2.6bn wiped off their collective market capitalization.
- Markets & Stocks
US Election Results See Cannabis Stocks Plummet, DanCann Initiates Capital Reduction, & More from Stenocare
Cannabis stocks plunge on election results As the outcome of the US presidential election and numerous state-specific cannabis ballots dripped through yesterday, the markets reacted in tandem.
- Markets & Stocks
Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week amid the release of its half-year results.
- Markets & Stocks
Little Green Pharma Stock Flies Amid Record Quarter, & Althea Sells UK Subsidiary
Little Green Pharma [stock_market_widget type=”chart” template=”line” assets=”LGP.AX” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Australian Stock Exchange (ASX) listed medical cannabis firm Little Green Pharma (LGP) saw its stock rally by over 60% this week after reporting record revenues.
- Markets & Stocks
Voyager Life Offloads Cannabis Operations, Stenocare Drops Sales Guidance for a Second Time, & More from Cantourage
Voyager Life [stock_market_widget type=”chart” template=”line” assets=”VOY.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after first announcing its intention to exit the space in June.
- Markets & Stocks
Ananda Announces Phase 1 Clinical Trial in Australia, Hellenic Suffers Further Funding Delays, & Flora Expands Reach in Germany
Hellenic Dynamics Hellenic Dynamics has announced a further delay in the receipt of a long-term €1m loan, which has already led to the delay in the publication of its full-year results and the suspension of its shares.
- Markets & Stocks
Ananda Stock Returns to AJ Bell Platform Following Backlash, Kanabo Stock Jumps 30% on Financial Results, & Argent Seeks to Shift Listing
Ananda Developments [stock_market_widget type=”chart” template=”line” assets=”ANA.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Ananda Developments’ CEO has seemingly forced the hand of one of the UK’s most popular investment service providers, AJ Bell, after it decided to cut a raft of smaller-cap companies from its online trading platform.
- Markets & Stocks
DanCann Pharma Planning Reverse Stock Split, Allied Corp Exports GMP Product to Swiss Market, & More from SEED
DanCann Pharma [stock_market_widget type=”chart” template=”line” assets=”DAN.F” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Danish cannabis company DanCann Pharma has announced plans to enact a reverse stock split aimed at ‘stabilising the trading of the company’s shares’.
- Markets & Stocks
Synbiotic’s CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure
Synbiotic [stock_market_widget type=”chart” template=”line” assets=”SBX.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] New research conducted by analysts at NuWays has given German buy-and-build cannabis brand Synbiotic an updated ‘buy’ recommendation.
